Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / CL A
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
31,493,925
-
Shares change
-
+3,086,063
-
Total reported value, excl. options
-
$3,210,703,884
-
Value change
-
+$331,269,481
-
Put/Call ratio
-
94%
-
Number of buys
-
111
-
Number of sells
-
-93
-
Price
-
$101.96
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2023
272 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q2 2023.
REATA PHARMACEUTICALS INC - CL A (RETA) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,493,925 shares
.
Largest 10 shareholders include CPMG Inc (2,896,901 shares), VANGUARD GROUP INC (2,821,537 shares), BlackRock Inc. (2,538,770 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,766,070 shares), DEUTSCHE BANK AG\ (1,486,467 shares), WELLINGTON MANAGEMENT GROUP LLP (1,472,043 shares), First Light Asset Management, LLC (1,432,208 shares), Boxer Capital, LLC (1,430,004 shares), JANUS HENDERSON GROUP PLC (1,051,077 shares), and STATE STREET CORP (713,150 shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.